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ABSTRACT: Herein, we describe the synthesis of unsymmetrically substituted dibenzo[f,h]furazano[3,4-b]quinoxalines by
intramolecular cyclization through direct transition metal-free C−H functionalization. The electrochemical and photophysical
properties for several polycycles have been measured. In thin films of the dibenzo[f,h]furazano[3,4-b]quinoxalines, hole mobility is in
the order of 10−4 cm2 V−1 s−1. The results show that the HOMO and LUMO energy levels are appropriate for using the compounds
as hole-transport materials in thin-film devices, in particular, organic and perovskite solar cells.
■ INTRODUCTION
Polycyclic heteroaromatic compounds have received much
attention as a fundamental framework in organic functional
materials because their electrochemical and photochemical
properties are useful in organic electronics and luminescent
materials.1 Among them, 1,4-diazatriphenylene (dibenzo[f,h]-
quinoxaline) derivatives (I) frequently appeared in a molecular
unit in the preparation of extended π-conjugated systems with
optical characteristic and electrochemical properties (Figure
1).2 One of the rare azoannulated 1,4-diazatriphenylene
derivatives is dibenzo[f,h]furazano[3,4-b]quinoxaline (II).
Only two publications reported the synthesis of dibenzo[f,h]-
furazano[3,4-b]quinoxalines (II) by condensation of substi-
tuted 9,10-phenanthroquinone with 3,4-diaminofurazan under
acidic reaction conditions.3 To the best of our knowledge,
there are no synthetic procedures that give the asymmetrically
substituted dibenzo[f,h]furazano[3,4-b]quinoxalines.
We previously reported that 5-(hetero)aryl-[1,2,5]-
oxadiazolo[3,4-b]pyrazines (III) participated in a transition
metal-free cross-coupling reactions with different nucleo-
philes.4 Therefore, our initial strategy toward dibenzo[f,h]-
furazano[3,4-b]quinoxalines assumed that acid-catalyzed intra-
molecular cyclization of aryl substituted 5-([1,1′-biphenyl]-2-
yl)-[1,2,5]oxadiazolo[3,4-b]pyrazines to furnish 9,13-
dihydrodibenzo[f,h][1,2,5]oxadiazolo[3,4-b]quinoxaline inter-
mediates, which could be further oxidized for the synthesis of
targets 1,4-diazatriphenylenes (II) (Scheme 1).
In this paper, we report a new synthetic protocol for the
preparation of unsymmetrically substituted dibenzo[f,h]-
furazano[3,4-b]quinoxalines and their photophysical and
electrochemical properties; moreover, we fabricated hole-only
devices to measure the hole mobility values in thin films.
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Figure 1. Dibenzo[f,h]quinoxaline (I) and dibenzo[f,h]furazano[3,4-
b]quinoxaline (II) derivatives.
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■ RESULTS AND DISCUSSION
Synthesis. At the first stage, the parent 5-(2-bromophen-
yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (3) was obtained via the
two-step procedure from readily available 2′-bromoacetophe-
none (1) in 79% overall yield (Scheme 2).
Further, it was necessary to synthesize the series of 5-([1,1′-
biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine derivatives.
5-(2-Bromophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (3) re-
acted with phenylboronic acid (4a) to give 5-([1,1′-
biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (5a) under
the Suzuki cross-coupling condition. Examination of the
palladium catalysts showed that Pd(PPh3)4 in dry 1,4-dioxane
gave the desired product 5a in the best yield (Table 1, entry 4).
Based on the above results, the structural diversity of various
arylboronic acids (4a−4h) was examined. As shown in Scheme
3, a wide range of mono-, di-, and trisubstituted phenylboronic
acids, bearing both electron-donating and electron-withdraw-
ing substituent groups, could react with 3 for the synthesis of
the corresponding 5-bis(aryl)-substituted [1,2,5]oxadiazolo-
[3,4-b]pyrazines (5a−5h). As can be seen, the electronic
character of the substituents of phenylboronic acids does not
have an influence on their reaction activity. In all cases, the
Suzuki cross-coupling occurred smoothly to give the desired
products 5a−5h in good yields of 51−82% (Scheme 3).
Next, we tried to intramolecular cyclize bis(aryl)-substituted
[1,2,5]oxadiazolo[3,4-b]pyrazines (5a−5h) into corresponding
9,13-dihydrodibenzo[f,h][1,2,5]oxadiazolo[3,4-b]quinoxaline
by action of CF3COOH as the best solvent, as shown earlier.
4
The intermediate products 6 were precipitated as white
powders in good yields of 56−95%. Notably, compounds 6b
and 6d were not isolated in their pure forms due to high
solubility in CF3COOH. In these cases, the solvent was
removed, and the resulting semisolid residue was oxidized to
desired 1,4-diazatriphenylenes 7b and 7d without additional
purification. Of note, it was found that 2,4-difluoro-9,13-
Scheme 1. Interaction of 5-(Hetero)aryl-[1,2,5]oxadiazolo[3,4-b]pyrazines with Different Nucleophiles through a Transition
Metal-Free Cross-Coupling Reactions
Scheme 2. Synthesis of 5-(2-Bromophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (3)
Table 1. Optimization of the Suzuki Cross-Coupling Reaction Conditions
entry Pd catalyst/ligand (equiv) base (2.5 equiv) PhB(OH)2 content (equiv) solvent yield (%)
1 Pd(PPh3)4 (5 mol %) K2CO3 2.0 1,4-dioxane/H2O (5:1) 16
2 Pd(PPh3)4 (10 mol %) K2CO3 2.0 1,4-dioxane/H2O (5:1) 45
3 Pd(OAc)2 (5 mol %)/PPh3 (10 mol %) K3PO4 2.0 1,4-dioxane 17
4 Pd(PPh3)4 (5 mol %) K3PO4 1.2 1,4-dioxane 66
Scheme 3. Synthesis of 5-([1,1′-Biphenyl]-2-yl)-
[1,2,5]oxadiazolo[3,4-b]pyrazine Derivatives (5a−5h)
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dihydrodibenzo[f,h][1,2,5]oxadiazolo[3,4-b]quinoxaline (6g)
is not formed under the given reaction conditions. We suggest
that it is due to the uncoordinated electron-withdrawing
inductive effect of two fluorine atoms, which complicate the
intramolecular electrophilic attack on the 1,1′-biphenyl
substituents. The obtained 9,13-dihydrodibenzo[f,h][1,2,5]-
Scheme 4. Synthesis Dibenzo[f,h]furazano[3,4-b]quinoxaline (DBFQ) Derivatives (7a−7h)
Scheme 5. Structure of Two Possible Regioisomers: 3-Fluorodibenzo[f,h][1,2,5]oxadiazolo[3,4-b]quinoxaline (7e) or 1-
Fluorodibenzo[f,h][1,2,5]oxadiazolo[3,4-b]quinoxaline (7e′)
Figure 2. 2D NMR NOESY (400 MHz, CDCl3) spectrum of 7e at 313 K.
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oxadiazolo[3,4-b]quinoxalines (6a−6f and 6h) were oxidized
with K3Fe(CN)6 in an alcohol solution (NaOH) for 24 h to
afford target dibenzo[f,h]furazano[3,4-b]quinoxalines (7a−7f
and 7h) in high yields of 69−96% (Scheme 4).
At the cyclization of the compound 5e, the formation of two
regioisomeric products, which differ at the C(1) or C(3)
position of the fluorine atom, is possible (Scheme 5). To
unambiguously confirm the structure of the polycyclic
compound 7e or 7e′, two-dimensional NOESY spectrum was
recorded for this compound (Figure 2). Particularly, for the
proposed structure of 7e′ in the NOESY spectrum, cross-peaks
due to spatial interactions of the protons H(2), H(3), and
H(4) forming the common system should be expected.
Besides, the interactions with neighboring protons H(2) and
H(4) should be observed for proton H(3). However, no cross-
peaks with any of the neighboring protons were detected for
proton H(4) in the NOESY experiment. Furthermore, for the
other protons of the aromatic system H(1) and H(2), the
interactions only with each other have been observed. This
evidence unambiguously supports the structure of 7e.
Notably, the structure of 7h was established by X-ray
diffraction analysis (Figure 3). According to the XRD data,
compound 7h crystallized in the noncentrosymmetric space
group. The polycyclic system is planar (Figure 3). The
fluoroaryl fragment is disordered in the plane with an
occupancy coefficient of 0.85/0.15. The mean bond distances
and angles of the molecules are near to standard. In the crystal,
the molecules form the twisted slanting stacks (Figure 4a−c),
with interfacial distances of adjacent molecules being
approximately 3.3 Å (Figure 4d), which is near the layer
distance in graphite (3.35 Å).5 This is a characteristic for a
pronounced π−π interaction between two aromatic cores.
These results suggest that the other analogue polycycles 7a and
7c−7f without the bulky propping tert-butyl group also may
hold strong intermolecular π−π stacking interactions. In fact,
relatively poor solubility was observed for 7d, 7e, and 7h,
which reflects the strong π−π interactions.6
Optical and Photophysical Properties. The electro-
chemical properties of dibenzo[f,h]furazano[3,4-b]-
quinoxalines (7a−7f and 7h) were studied using cyclic
voltammetry under conditions previously described for similar
heteroacene systems.7 The cyclic voltammograms shown in
Figures S1−S7 demonstrate the irreversible character of the
reduction of compounds 7a−7f and 7h. Given that no anodic
behavior of 1,4-diazatriphenylenes (7a−f and h) could be
recorded by CV, their excited state oxidation potentials
(corresponding to the HOMO energy levels) were calculated
by subtracting the optical energy gap Eg
opt (estimated from the
long-wavelength absorption edge of the absorption spectra8
recorded in CH2Cl2 solution shown in Figures S8−S14) from
the LUMO energy values (Table 2). The compounds under
study are considered to be used in the solid state, so the similar
optical and electrochemical parameters, as well as hole mobility
(Table 2), were measured in their thin solid films (see
Experimental Section). Both HOMO and LUMO energy levels
of the compounds in solution are downshifted compared with
those in solid films because of the influence of the
reorganization energy of the electrolyte on the dispersion of
the energy level of the substance in solution.
Computational Data. The DFT calculations of the
HOMO levels and the energy gap, as well as the dipole
moment of molecules in the neutral state, were done at the
B3LYP/6-31G* level of theory in vacuum.9 The computational
data are shown in Table 2. The results show that the HOMO
and LUMO levels were uniformly overestimated in the DFT
calculations, presumably because the calculations were
performed in a vacuum. The calculated band gap energies
Eg
calc are systematically higher than the experimental Eg
opt
values.
Hole Mobility. Organic semiconductors that can poten-
tially be used as a charge-transporting material must possess
reasonable charge carrier mobility values. Thus, we prepared
specimens of a diode structure ITO/SiO2/ DBFQ/Au where
the SiO2 insulator layer blocked injection of charge carriers
from the ITO electrode in CELIV measurements (see
Experimental Section). The data on hole mobility in the
solid films of dibenzo[f,h]furazano[3,4-b]quinoxalines are also
summarized in Table 2. The hole mobility in the 7a, 7d, and
7e films is 2.5−6 times larger than that in the 7b, 7c, 7f, and 7h
films.
The charge carrier transport in organic and polymer solids
can be represented in terms of the redox process.10−13 The
hole transport is considered as a chain of redox reactions,
consisting of one electron transfer from the HOMO of the
neutral molecules to the single occupied molecular orbital
(SOMO) of the neighbor radical cations. When the neutral
molecule is charged positively, its conformation is transformed
to accommodate the minimum energy state of the radical
cation. In turn, when the SOMO of the radical cation accepts
the second electron, its conformation is also transformed.
Evidently, such molecule reorganization influences the
probability of the intermolecular electron transfer and, as a
consequence, the mobility of charge carriers. Indeed, molecule
7a consists of a solid core backbone, whereas other molecules
have substituents, which can cause molecule conformation
transformations during charge transfer. The fluorine sub-
stituent in the 7d and 7e molecules seems to initiate negligible
transformations between the charged and neutral states of the
molecules, so the high hole mobility for their films obeys the
suggested approach as well.
It is understood that the packing of the molecules in solid
films influences the charge carrier transport. As was discussed
above, 7a and 7c−7h molecules tend to form strong
intermolecular π−π stacking interactions. In consequence, we
can expect relatively high charge mobility in their films in
accordance with the fact that charge transport along the axis of
such stack is faster than in any other direction.13 Nevertheless,
the hole mobility in the 7c, 7f, and 7h films is lower than that
Figure 3. ORTEP of 7h with thermal ellipsoids at the 50% probability
level.
ACS Omega http://pubs.acs.org/journal/acsodf Article
https://dx.doi.org/10.1021/acsomega.0c00479
ACS Omega 2020, 5, 8200−8210
8203
in the 7a, 7d, and 7e films. In this regard, the dipole nature of
the bulk of the films may be taken into account as well.14,15
In accordance with the well-developed correlated disorder
model (CDM),15 considering the Gaussian distribution of
density of states, the following relationship describes charge
mobility (see eq 1)
μ μ σ σ
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where C0 = 0.78, Γ = 2, μ0 is the pre-exponential factor, R is
the distance between charge transport sites, F is the applied
electric field, e is the electron charge, k is the Boltzmann
constant, T is the temperature, and σ is the root mean square
width of the energetic disorder. In general, the latter is
determined by a dipolar component, σd, a van der Waals
component, σv, and a quadrupolar component, σq, so as σ
2 =
σd
2 + σv
2 + σq
2. To a quite good approximation, the
contribution of the van der Waals and quadrupolar
components may be neglected in comparison with the dipolar
component, which is given by σd = 2.35ep/(εR) where p is the
dipole moment of the transport molecule and ε is the
permanent dielectric constant of the medium. It is seen that
the lower the molecule dipole moment, the lower the
amplitude of disorder and hence the larger the charge carrier
mobility in the solid film. This correlation is revealed for 7d
and 7e molecules, possessing the lower dipole moment
compared with the 7c, 7f, and 7h molecules (Table 2).
Meanwhile, the correlation fails if 7a molecules are compared
to the 7b, 7f, and 7h molecules, with the molecules possess a
similar dipole moment. It means that the CDM does not apply
to the 7a films. We may suppose that the degree of ordering
(stacking) of the 7a molecules in the film formed on a glass/
ITO/SiO2 substrate is higher than that of the 7b, 7f, and 7h
molecules.
■ CONCLUSIONS
In summary, we have developed a new approach for the
synthesis of unsymmetrical dibenzo[f,h]furazano[3,4-b]-
quinoxalines via intramolecular oxidative cyclodehydrogena-
tion of the corresponding 5-phenylaryl(hetaryl)-substituted
[1,2,5]oxadiazolo[3,4-b]pyrazines. The present synthetic pro-
cedure provides a facile way to the family of nitrogen-
containing polycyclic heteroaromatic compounds that can
potentially be used in organic electronics and luminescent
materials.
Namely, we observed that a compromise between molecule
stiffness, molecule dipole moment, and intermolecular pack-
aging defines the mobility of holes in the solid films of the
dibenzo[f,h]furazano[3,4-b]quinoxalines. In the films, hole
mobility in the order of 10−4 cm2 V−1 s−1 was experimentally
measured, which makes the compounds promising hole-
transporting materials for organic electronics. In particular,
7b−7h compounds are promising candidates for the hole-
transport layer in perovskite solar cells. Under similar
conditions, the CELIV mobility of the pristine staple-
compound Spiro-MeOTAD,16 which is commonly used as
the hole-transport layer, was 8.5 × 10−7 cm−2 V−1 s−1 (for
comparison, the hole mobility obtained from space charge
limited current and time-of-flight measurements reached 2 ×
Figure 4. Molecular packing for 7h (a) in the plane [100], (b) along the plane [8 24 0], and (c) in the plane [001]. (d) Fragment of stack with
interfacial distances in Å.
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10−4 cm−2 V−1 s−1 at high field).17 Moreover, their HOMO
levels match well with those of MAPbI3 and MAPbBr3 hybrid
perovskites.
■ EXPERIMENTAL SECTION
All reagents and solvents were obtained from commercial
sources and dried by using standard procedures before use.
1H and 13C NMR spectra were recorded on AVANCE 500
and AVANCE II 400 MHz instruments using Me4Si as an
internal standard. Elemental analysis was carried on a
Eurovector EA 3000 automated analyzer. Melting points
were determined on Boetius combined heating stages and
were not corrected.
Flash column chromatography was carried out using Alfa
Aesar silica gel 0.040−0.063 mm (230−400 mesh), eluting
with ethyl acetate/hexane. The progress of reactions and the
purity of compounds were checked by TLC on Sorbfil plates
(Russia) in which the spots were visualized with UV light (λ,
254 or 365 nm).
The XRD experiment was performed on an Xcalibur 3
diffractometer on the standard procedure (MoK irradiation,
graphite monochromator, ω scans with 1° step at T = 295(2)
K). Empirical absorption correction was applied. Using
Olex2,18 the structure was solved with the Superflip19 structure
solution program using charge flipping and refined with the
olex2.refine refinement package using Gauss−Newton mini-
mization. All nonhydrogen atoms were refined in anisotropic
approximation; H atoms were refined isotropically in the
“rider” model. The mean crystallographic data and results of
the refinements are presented in Table S1. The X-ray
crystallography data for the structure reported in this paper
have been deposited with Cambridge Crystallography Data
Centre as supplementary publications CCDC 1976356 for 7h.
These data can be obtained free of charge from the Cambridge
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_
request/cif.
Cyclic voltammetry was carried out on a Metrohm Autolab
PGSTAT128N potentiostat with a standard three-electrode
configuration. Typically, a three-electrode cell equipped with a
platinum working electrode, a Ag/AgNO3 (0.01 M) reference
electrode, and a glass carbon rod counter electrode was
employed. The measurements were done in dichloromethane
solution, containing the present compound (5 × 10−3 M) with
tetrabutylammonium perchlorate (0.1 M) as the supporting
electrolyte under an argon atmosphere at a scan rate of 100
mV s−1. The potential of the reference electrode was calibrated
by using the ferrocene/ferrocenium redox couple (Fc/Fc+),
which has a known oxidation potential of +5.1 eV versus
vacuum for ferrocene.20 After calibration of the measurements
against Fc/Fc+, the HOMO energy level was calculated
according to the following equation (eq 2)
= −[ − + ]+E E E(eV) (Fc/Fc ) 5.1HOMO oxonset 1/2 (2)
where E1/2(Fc/Fc
+) is the half-wave potential of the Fc/Fc+
couple (the oxidation potential of which is assumed at 5.1 eV)
against the Ag/Ag+ electrode.
Table 2. Optical, Electrochemical, and Hole Mobility Data for Dibenzo[f,h]furazano[3,4-b]quinoxalines
compound
Ered
onseta
(V)
EHOMO
b/
EHOMO
c (eV)
ELUMO
b,d/
ELUMO
c,d (eV)
Eg
optb/Eg
optc
(±0.03 eV)
Absorptionb λmax (nm)/ε
(103 M−1 cm−1)
hole mobilityc
(10−5 cm2 V−1 s−1) (CIe 95%)
dipole
momentf (D)
7a −0.81 −7.15/−5.61 −4.29/−3.01 2.86/2.60 387/12.95 12.7 ± 1.5 6.81
305/21.35
294/13.52
267/19.20
7b −0.83 −7.12/−5.23 −4.27/−2.68 2.85/2.55 389/14.21 2.5 ± 0.5 6.87
308/21.46
297/15.73
275/25.02
7c −0.93 −6.74/−5.24 −4.17/−3.04 2.57/2.20 412/13.80 5.1 ± 0.4 8.62
311/15.98
279/29.98
253/49.20
7d −0.75 −7.11/−5.23 −4.35/−2.99 2.76/2.24 395/12.43 16.0 ± 4.0 5.43
304/20.16
293/12.97
7e −0.80 −7.16/−5.27 −4.30/−2.72 2.86/2.55 386/14.73 13.3 ± 1.6 5.57
303/20.52
292/13.24
275/22.76
7f −0.75 −7.25/−5.25 −4.35/−2.80 2.90/2.45 384/11.85 2.4 ± 0.4 6.77
307/26.34
296/16.82
271/18.09
7h −0.78 −7.18/−5.27 −4.32/−2.87 2.87/2.40 384/14.54 3.5 ± 1.6 6.57
301/16.47
290/11.49
267/21.02
aEred
onset, onset of reduction potential (vs Ag/AgCl reference electrode). bParameters measured in solutions at room temperature at C = 1.0 × 10−5
M (for optical) and C = 5.0 × 10−3 M (for electrochemical). cParameters measured for solid films at room temperature. dELUMO = EHOMO − Egopt.
eConfidence interval calculated from 10 replicates. fDFT calculation data.
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UV−vis spectra were recorded for a 1 × 10−5 M
dichloromethane solution with a Shimadzu UV-2401PC
spectrophotometer.
Since some of the dibenzo[f,h]furazano[3,4-b]quinoxaline
derivatives under study were poor soluble, their thin solid films
were prepared by thermal evaporation in vacuum. The
morphology of the film was not studied. In thin layers of the
dibenzo[f,h]furazano[3,4-b]quinoxaline derivatives, HOMO−
LUMO energy levels were determined by cyclic voltammetry
(CV). The CV experiment was carried out at a scan rate of 20
mV s−1 in a three-electrode, three-compartment electro-
chemical cell in the glovebox with a dry argon atmosphere.
Platinum sheets served as working and counter electrodes. A
20 nm solid layer of an examined material was preliminarily
deposited onto the working electrode by thermal evaporation
of the compound under 10−6 mbar vacuum at a rate of 1 Å s−1.
A 0.2 M solution of tetrabutylammonium hexafluorophosphate
(NBu4PF6, Fluka) in acetonitrile (MeCN (Aldrich, HPLC-
grade)) was used as an electrolyte. The electrolyte solution was
prepared as follows. To remove impurities and traces of water,
MeCN was stirred with calcium hydride (10 g L−1) for 2 days,
fractionally distilled with P2O5 (5 g L
−1), then heated near the
boiling point for 2 h with CaH2 (5 g L
−1), and finally
fractionally distilled again. NBu4PF6 was purified by recrystal-
lization in ethanol and then dried and heated for 4 h at 80 °C
in the inert dry argon atmosphere in the glovebox. The
electrolyte solution was prepared in the glovebox also. A Ag
wire immersed into the electrolyte solution with the addition
of 0.1 M AgNO3 was used as a pseudo reference electrode
(Ag/Ag+). It was calibrated against ferrocene/ferrocenium
couple (−0.039 V vs Ag/Ag+), and its potential was
recalculated to the energy scale using a value of −4.988 eV
for Fc/Fc+ in MeCN reported in the literature.21 Thus, the
energy level of Ag/Ag+ (EAg/Ag+) in this case is −5.027 eV.
Considering the accuracy of CVA experiment (±0.02 V), this
value should be rounded to −5.03 eV.
A 20 nm solid film of an examined material was deposited
onto the working electrode by thermal evaporation of the
compound under 10−6 mbar vacuum at a rate of 1 Å s−1. The
values of potentials corresponding to the HOMO levels were
determined by applying a tangent to the onset of anodic and
cathodic currents, followed by extrapolation of the tangent to
zero current at the crossing with the axis of potentials. For all
the substances, we failed to determine the LUMO level
because of the rather wide optical band gap ranged around
2.4−2.6 eV. Therefore, considering the determined electro-
chemical response of HOMO, the response of LUMO should
lay in the range of potentials near −2.4 V, which is close to the
cathodic limit of the electrochemical stability window of
MeCN.
Charge Carrier Mobility Measurements. In thin solid
films, the charge mobility values were measured by using the
technique of charge extraction by linearly increasing voltage
(CELIV).22 Metal−insulator−semiconductor (MIS) diode
structures, similar to those described in references,23,24 were
prepared.
Onto the ITO (indium tin oxide) electrode of the ITO/glass
substrate, a SiO2 insulator layer of 70 nm in thickness was
deposited by conventional magnetron sputtering. Then, a 100
nm layer of the dibenzo[f,h]furazano[3,4-b]quinoxaline
derivative and an 80 nm layer of the Au electrode were
deposited successively by thermal evaporation of the material
under 10−6 mbar vacuum at a rate of 1 Å s−1.
For CELIV measurements, an arbitrary waveform generator
and oscilloscope (DLAnalog Discovery with WaveForms
software) were used to generate the triangle voltage pulse
with a proper ramp and offset. CELIV signals were recorded by
a digital storage oscilloscope (Tektronix TDS3032B) as well.
The charge carrier mobility μ was determined in accordance
with eq 322
μ =
+ Δ
d
At
2
3 1 j
j
2
max
2 0.36
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ÅÅÅÅÅÅÅ
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Ö
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where d is the film thickness, A is the applied voltage ramp,
j(0) is the displacement current, and Δj is the maximum drift
current at “tmax”. The latter three parameters were extracted
from CELIV transient current curves.
Synthesis of 5-(2-Bromophenyl)-[1,2,5]oxadiazolo-
[3,4-b]pyrazine (3). Selenium dioxide (1.1 g, 10 mmol)
was dissolved in 1,4-dioxane/H2O (15:1, 16 mL), and the
mixture was heated and refluxed for 5 min. 2′-Bromoaceto-
phenone (1) (1.99 g, 10 mmol) was added, and heating was
continued for the next 12 h. The reaction mixture was filtered,
and the filtrate was concentrated under reduced pressure to
give 2-bromophenylglyoxal as a light yellow oil. The solution of
3,4-diaminofurazan (2) (1.0 g, 10 mmol) and crude 2-
bromophenylglyoxal in a mixture of EtOH (5 mL) and
CH3COOH (5 mL) was refluxed for 1 h. After that, the
mixture was cooled down, and the precipitate was filtered off,
washed with ethanol, and then air-dried. The desired product 3
was obtained as a crystalline yellow powder. Yield: 2.19 g, 79%.
mp 135 °C. 1H NMR (500 MHz, DMSO-d6): δ 9.44 (s, 1H),
7.91 (dd, J = 8.0, 1.1 Hz, 1H), 7.79 (dd, J = 7.6, 1.7 Hz, 1H),
7.68 (td, J = 7.6, 1.1 Hz, 1H), 7.63−7.59 (m, 1H). 13C NMR
(126 MHz, DMSO-d6): δ 162.4, 157.1, 151.9, 151.1, 136.1,
133.4, 133.1, 132.4, 128.5, 121.0. Calcd for C10H5BrN4O
(277.08): C, 43.35; H, 1.87; N, 20.22. Found: C, 43.41; H,
1.84; N, 20.10.
General Procedure for the Synthesis of 5-([1,1′-
Biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine Deriva-
tives (5a−5h). A mixture of 5-(2-bromophenyl)-[1,2,5]-
oxadiazolo[3,4-b]pyrazine (1) (277 mg, 1.0 mmol), corre-
sponding arylboronic acids 4a−4h (1.2 mmol), Pd(PPh3)4
(115 mg, 10 mol %), and K3PO3 (530 mg, 2.5 mmol) was
dissolved in 1,4-dioxane (15 mL). The reaction mixture was
degassed and refluxed for 15 h under an argon atmosphere.
After completion of the reaction (monitored by TLC), 10 mL
of water was added and extracted with ethyl acetate. The
combined organic layer was washed with water and brine,
dried over anhydrous Na2SO4, and concentrated in vacuo.
Purification by silica gel column chromatography with ethyl
CH2Cl2/hexane (1:2, v/v) as an eluent and recrystallization
from EtOH were performed to afford the title compounds
(5a−5h).
5-([1,1′-Biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine
(5a). Yield: 182 mg, 66%, pale yellow powder. mp 143 °C. 1H
NMR (400 MHz, DMSO-d6): δ 8.25 (s, 1H), 7.93 (dd, J = 8.0,
1.2 Hz, 1H), 7.81−7.77 (m, 1H), 7.71−7.67 (m, 2H), 7.40−
7.36 (m, 3H), 7.32−7.27 (m, 2H). 13C NMR (101 MHz,
DMSO-d6): δ 163.9, 156.6, 152.2, 150.7, 141.2, 139.0, 134.1,
132.0, 131.5, 130.5, 129.9, 129.1, 128.34, 128.32. Calcd for
C16H10N4O (274.28): C, 70.06; H, 3.68; N, 20.43. Found: C,
70.03; H, 3.74; N, 20.36.
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5-(4′-tert-Butyl-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo-
[3,4-b]pyrazine (5b). Yield: 270 mg, 82%, pale yellow powder.
mp 142 °C. 1H NMR (400 MHz, DMSO-d6): δ 8.24 (s, 1H),
7.91 (d, J = 7.8 Hz, 1H), 7.80−7.75 (m, 1H), 7.70−7.64 (m,
2H), 7.41 (d, J = 7.9 Hz, 2H), 7.23 (d, J = 7.9 Hz, 2H), 1.28
(s, 9H). 13C NMR (101 MHz, DMSO-d6): δ 164.0, 156.6,
152.3, 151.0, 150.7, 141.1, 136.1, 134.0, 132.0, 131.5, 130.5,
129.6, 128.2, 125.9, 34.3, 31.0. Calcd for C20H18N4O (330.39):
C, 72.71; H, 5.49; N, 16.96. Found: C, 72.51; H, 5.40; N,
17.18.
5-(3′,4′,5′-Trimethoxy-[1,1′-biphenyl]-2-yl)-[1,2,5]-
oxadiazolo[3,4-b]pyrazine (5c). Yield: 298 mg, 82%, orange
powder. mp 154 °C. 1H NMR (500 MHz, DMSO-d6): δ 8.30
(s, 1H), 7.92 (d, J = 7.6 Hz, 1H), 7.80−7.72 (m, 2H), 7.70−
7.66 (m, 1H), 6.52 (s, 2H), 3.67 (s, 3H), 3.58 (s, 6H). 13C
NMR (126 MHz, DMSO-d6): δ 164.1, 156.8, 153.2, 152.1,
150.5, 141.3, 137.7, 134.6, 134.0, 132.0, 131.3, 130.3, 128.3,
107.6, 60.1, 55.9. Calcd for C19H16N4O4 (364.36): C, 62.63;
H, 4.43; N, 15.38. Found: C, 62.43; H, 3.53; N, 15.26.
5-(2′-Fluoro-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-
b]pyrazine (5d). Yield: 210 mg, 72%, pale yellow powder. mp
151 °C. 1H NMR (500 MHz, DMSO-d6): δ 8.75 (s, 1H), 7.98
(dd, J = 7.7, 1.0 Hz, 1H), 7.80 (td, J = 7.6, 1.3 Hz, 1H), 7.73
(td, J = 7.6, 1.1 Hz, 1H), 7.65 (d, J = 7.6 Hz, 1H), 7.46−7.39
(m, 2H), 7.26 (td, J = 7.6, 0.8 Hz, 1H), 7.18−7.13 (m, 1H).
13C NMR (126 MHz, DMSO-d6): δ 162.9, 158.4 (d,
1JC,F =
245.1 Hz), 156.5, 151.8, 150.7, 134.8 (d, 4JC,F = 4.8 Hz), 132.2
(d, 4JC,F = 2.8 Hz), 131.8, 131.5, 130.9, 130.8 (d,
3JC,F = 8.4
Hz), 128.9, 126.6, 126.5, 125.2 (d, 4JC,F = 3.5 Hz), 115.9 (d,
2JC,F = 22.1 Hz).
19F NMR (471 MHz, DMSO-d6): δ 45.87
(ddd, J = 10.6, 7.7, 5.4 Hz) ppm. Calcd for C16H9FN4O
(292.27): C, 65.75; H, 3.10; N, 19.17. Found: C, 65.70; H,
3.05; N, 19.24.
5-(3′-Fluoro-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-
b]pyrazine (5e). Yield: 210 mg, 72%, pale yellow powder. mp
153 °C. 1H NMR (500 MHz, DMSO-d6): δ 8.42 (s, 1H), 7.94
(dd, J = 7.6, 0.9 Hz, 1H), 7.79 (td, J = 7.5, 1.3 Hz, 1H), 7.71
(ddd, J = 9.9, 5.6, 1.7 Hz, 2H), 7.35 (td, J = 7.9, 6.3 Hz, 1H),
7.32−7.28 (m, 1H), 7.24 (td, J = 8.4, 2.1 Hz, 1H), 6.99 (d, J =
7.8 Hz, 1H). 13C NMR (126 MHz, DMSO-d6): δ 163.3, 162.3
(d, 1JC,F = 245.4 Hz), 156.7, 152.2, 150.7, 141.4 (d,
3JC,F = 7.9
Hz), 139.9 (d, 4JC,F = 2.1 Hz), 134.4, 132.0, 131.6, 130.9 (d,
3JC,F = 8.6 Hz), 130.7, 128.8, 126.5 (d,
4JC,F = 2.7 Hz), 116.4
(d, 2JC,F = 22.0 Hz), 115.2 (d,
3JC,F = 21.0 Hz).
19F NMR (471
MHz, DMSO-d6): δ 50.83−50.78 (m). Calcd for C16H9FN4O
(292.27): C, 65.75; H, 3.10; N, 19.17. Found: C, 65.68; H,
3.17; N, 19.35.
5-(4′-Fluoro-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-
b]pyrazine (5f). Yield: 232 mg, 80%, pale yellow powder. mp
151 °C. 1H NMR (500 MHz, DMSO-d6): δ 8.35 (s, 1H), 7.92
(dd, J = 7.6, 0.8 Hz, 1H), 7.78 (td, J = 7.6, 1.2 Hz, 1H), 7.70−
7.65 (m, 2H), 7.36−7.32 (m, 2H), 7.23−7.17 (m, 2H). 13C
NMR (126 MHz, DMSO-d6): δ 163.6, 162.07 (d,
1JC,F = 246.3
Hz), 156.7, 152.2, 150.7, 140.2, 135.4 (d, 4JC,F = 3.0 Hz),
134.1, 132.1, 132.0 (d, 4JC,F = 3.8 Hz), 131.5, 130.6, 128.4,
116.0 (d, 2JC,F = 21.6 Hz).
19F NMR (471 MHz, DMSO-d6): δ
48.91 (dq, J = 8.9, 5.4 Hz). Calcd for C16H9FN4O (292.27): C,
65.75; H, 3.10; N, 19.17. Found: C, 65.63; H, 3.04; N, 19.17.
5-(2′,4′-Difluoro-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo-
[3,4-b]pyrazine (5g). Yield: 214 mg, 69%, yellow powder. mp
141 °C. 1H NMR (500 MHz, DMSO-d6): δ 8.86 (s, 1H), 7.99
(dd, J = 7.7, 1.2 Hz, 1H), 7.80 (td, J = 7.6, 1.4 Hz, 1H), 7.74
(td, J = 7.6, 1.3 Hz, 1H), 7.63 (d, J = 7.6 Hz, 1H), 7.47 (td, J =
8.7, 6.6 Hz, 1H), 7.22 (ddd, J = 10.6, 9.4, 2.5 Hz, 1H), 7.15
(td, J = 8.4, 2.3 Hz, 1H). 13C NMR (126 MHz, DMSO-d6): δ
162.6, 162.2 (dd, 1JC,F = 248.2,
3JC,F = 12.3 Hz), 158.5 (dd,
1JC,F = 247.7,
3JC,F = 12.6 Hz), 156.5, 151.7, 150.7, 134.7,
134.0, 133.3 (dd, 3JC,F = 9.8,
4JC,F = 4.3 Hz), 131.8, 131.5,
130.9, 129.9 (d, 1JC,F = 240.1 Hz), 123.2 (dd,
2JC,F = 15.0,
4JC,F
= 3.8 Hz), 112.3 (dd, 2JC,F = 21.3,
4JC,F = 3.6 Hz), 104.3 (t,
2JC,F = 26.4 Hz).
19F NMR (471 MHz, DMSO-d6): δ 53.22−
53.15 (m, 1F), 50.70 (dd, J = 18.8, 8.9 Hz, 1F). Calcd for
C16H8F2N4O (310.26): C, 61.94; H, 2.60; N, 18.06. Found: C,
61.91; H, 2.70; N, 18.26.
5-(3′,5′-Difluoro-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo-
[3,4-b]pyrazine (5h). Yield: 160 mg, 51%, yellow powder. mp
124 °C. 1H NMR (400 MHz, DMSO-d6): δ 8.62 (s, 1H),
7.99−7.96 (m, 1H), 7.82−7.71 (m, 2H), 7.70−7.67 (m, 1H),
7.33−7.25 (m, J = 9.3, 2.2 Hz, 1H), 7.11−7.04 (m, 2H). 13C
NMR (101 MHz, DMSO-d6): δ 162.6, 162.3 (dd,
1JC,F =
247.8, 3JC,F = 13.5 Hz), 156.7 (t,
2JC,F = 23.8 Hz), 152.1, 150.8,
142.9 (t, 3JC,F = 9.8 Hz), 139.1, 134.0, 132.0 (d,
3JC,F = 6.6 Hz),
131.6 (d, 2JC,F = 18.5 Hz), 130.9, 129.1, 113.2 (dd,
2JC,F = 25.8,
2JC,F = 18.1 Hz), 103.6 (td,
2JC,F = 25.7,
2JC,F = 15.2 Hz).
19F
NMR (376 MHz, DMSO): δ 54.04−53.9 (m). Calcd for
C16H8F2N4O (310.26): C, 61.94; H, 2.60; N, 18.06. Found: C,
62.11; H, 2.62; N, 18.00.
General Procedure for the Synthesis of Dibenzo[f,h]-
[1,2,5]oxadiazolo[3,4-b]quinoxaline Derivatives (7a−
7h). Corresponding 5-([1,1′-biphenyl]-2-yl)-[1,2,5]-
oxadiazolo[3,4-b]pyrazine derivatives 5a−5h (0.5 mmol)
were dissolved in CF3COOH (3 mL). The resulting mixture
was stirred for 3 h at room temperature; the precipitate formed
was filtered off, washed with MeCN (3 × 3 mL), and dried.
The obtained 9,13-dihydrodibenzo[f,h][1,2,5]oxadiazolo[3,4-
b]quinoxaline derivatives 6a−6h were analyzed and further
oxidized by the addition of the solution of NaOH (112 mg, 2.0
mmol, 4 equiv) and K3Fe(CN)6 (329 mg, 1.0 mmol, 2 equiv)
in the mixture of EtOH/H2O (1:5, v/v). The resulting mixture
was stirred for 24 h at room temperature and diluted with H2O
(10 mL), and a precipitate was formed and filtered off. The
residue was purified by flash column chromatography with
CH2Cl2 as an eluent to afford the desired dibenzo[f,h][1,2,5]-
oxadiazolo[3,4-b]quinoxaline derivatives (7a−7h).
9,13-Dihydrodibenzo[f,h][1,2,5]oxadiazolo[3,4-b]-
quinoxaline (6a). Yield: 130 mg, 95%, white powder. mp 228
°C. 1H NMR (400 MHz, DMSO-d6): δ 9.95 (s, 2H), 8.77 (d, J
= 8.2 Hz, 2H), 8.21 (d, J = 8.2 Hz, 2H), 7.68−7.64 (m, 2H),
7.60−7.57 (m, 2H). 13C NMR (101 MHz, DMSO-d6): δ
148.0, 127.2, 126.6, 125.1, 123.2, 122.9, 120.5, 118.1. Calcd for
C16H10N4O (274.28): C, 70.06; H, 3.68; N, 20.43. Found: C,
70.15; H, 3.79; N, 20.44.
2-(tert-Butyl)-9,13-dihydrodibenzo[f,h][1,2,5]oxadiazolo-
[3,4-b]quinoxaline (6b). This substance could not be isolated
in its pure form.
1,2,3-Trimethoxy-9,13-dihydrodibenzo[f,h][1,2,5]-
oxadiazolo[3,4-b]quinoxaline (6c). Yield: 170 mg, 93%, white
powder. mp 221 °C. 1H NMR (500 MHz, DMSO-d6): δ 9.80
(s, 1H), 9.69 (s, 1H), 8.74 (d, J = 8.3 Hz, 1H), 8.12 (d, J = 8.3
Hz, 1H), 8.03 (s, 1H), 7.64−7.59 (m, 1H), 7.57−7.51 (m, J =
7.5 Hz, 1H), 4.04 (s, 3H), 3.97 (s, 3H), 3.91 (s, 3H). 13C
NMR (126 MHz, DMSO-d6): δ 151.5, 148.5, 147.9, 147.1,
142.2, 127.2, 125.6, 124.9, 124.4, 123.9, 122.6, 120.2, 118.2,
116.7, 111.2, 101.5, 62.5, 60.8, 56.1. Calcd for C19H16N4O4
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(364.36): C, 62.63; H, 4.43; N, 15.38. Found: C, 62.59; H,
4.55; N, 15.38.
4-Fluoro-9,13-dihydrodibenzo[f,h][1,2,5]oxadiazolo[3,4-
b]quinoxaline (6d). This substance could not be isolated in its
pure form.
3-Fluoro-9,13-dihydrodibenzo[f,h][1,2,5]oxadiazolo[3,4-
b]quinoxaline (6e). Yield: 130 mg, 89%, white powder. mp
245 °C. 1H NMR (400 MHz, DMSO-d6): δ 9.96 (s, 1H), 9.90
(s, 1H), 8.72 (d, J = 8.2 Hz, 1H), 8.54 (dd, J = 11.5, 2.4 Hz,
1H), 8.23 (dd, J = 9.2, 5.6 Hz, 1H), 8.18 (d, J = 8.3 Hz, 1H),
7.69−7.64 (m, J = 7.5 Hz, 1H), 7.59−7.50 (m, 2H). 13C NMR
(101 MHz, DMSO-d6): δ 156.0 (d,
1JC,F = 242.3 Hz), 148.0
(d, 4JC,F = 3.5 Hz), 128.4 (d,
3JC,F = 8.3 Hz), 127.8, 125.9 (d,
4JC,F = 4.0 Hz), 125.0, 123.8, 123.4, 123.2, 123.1, 120.4 (d,
3JC,F
= 10.6 Hz), 119.8, 118.1, 117.7 (d, J = 2.3 Hz), 115.9 (dd, 2JC,F
= 23.7, 4JC,F = 4.3 Hz), 108.40 (dd,
2JC,F = 22.6,
4JC,F = 3.2
Hz).19F NMR (376 MHz, DMSO-d6): δ 47.05 (ddd, J = 11.5,
8.1, 5.7 Hz). Calcd for C16H9FN4O (292.27): C, 65.75; H,
3.10; N, 19.17. Found: C, 65.63; H, 3.14; N, 19.19.
2-Fluoro-9,13-dihydrodibenzo[f,h][1,2,5]oxadiazolo[3,4-
b]quinoxaline (6f). Yield: 84 mg, 56%, white powder. mp 267
°C. 1H NMR (400 MHz, DMSO-d6): δ 10.02 (s, 1H), 9.86 (s,
1H), 8.82 (dd, J = 9.2, 5.9 Hz, 1H), 8.72 (d, J = 8.0 Hz, 1H),
8.20 (d, J = 8.1 Hz, 1H), 8.01 (dd, J = 11.7, 2.4 Hz, 1H), 7.68−
7.56 (m, 2H), 7.43 (td, J = 9.0, 2.4 Hz, 1H). 13C NMR (101
MHz, DMSO-d6): δ 161.4 (d,
1JC,F = 243.5 Hz), 147.9 (d,
4JC,F
= 3.2 Hz), 127.0, 126.4, 126.2 (d, 3JC,F = 9.3 Hz), 125.5, 124.4
(d, 3JC,F = 9.3 Hz), 123.4, 123.4, 123.2, 122.4, 120.5, 119.5,
117.7 (d, 4JC,F = 3.7 Hz), 113.5 (d,
2JC,F = 23.6 Hz), 105.4 (d,
2JC,F = 24.0 Hz).
19F NMR (471 MHz, DMSO-d6): δ 49.61−
49.55 (m). Calcd for C16H9FN4O (292.27): C, 65.75; H, 3.10;
N, 19.17. Found: C, 65.73; H, 3.21; N, 19.37.
2,4-Difluoro-9,13-dihydrodibenzo[f,h][1,2,5]oxadiazolo-
[3,4-b]quinoxaline (6g). This substance was not detected in
the reaction mixture by 1H NMR.
1,3-Difluoro-9,13-dihydrodibenzo[f,h][1,2,5]oxadiazolo-
[3,4-b]quinoxaline (6h). Yield: 120 mg, 77%, white powder.
mp 231 °C. 1H NMR (400 MHz, DMSO-d6): δ 9.96 (s, 1H),
9.07 (d, J = 10.9 Hz, 1H), 8.75 (d, J = 8.1 Hz, 1H), 8.50 (dd, J
= 11.0, 1.4 Hz, 1H), 8.21 (d, J = 8.2 Hz, 1H), 7.72 (td, J = 8.0,
0.7 Hz, 1H), 7.64−7.53 (m, 1H). The 13C NMR spectrum
cannot be correctly described in view of the extremely low
solubility of 6h in common organic solvents. 19F NMR (376
MHz, DMSO): δ 53.76 (ddd, J = 14.3, 11.2, 7.4 Hz, 1F),
49.51−49.44 (m, 1F). Calcd for C16H8F2N4O (310.26): C,
61.94; H, 2.60; N, 18.06. Found: C, 61.83; H, 2.72; N, 18.12.
Dibenzo[f,h][1,2,5]oxadiazolo[3,4-b]quinoxaline (7a).
Yield: 170 mg, 73%, red powder. mp 281 °C. 1H NMR (400
MHz, DMSO-d6): δ 8.31 (d, J = 8.0 Hz, 2H), 8.03 (dd, J = 7.7,
1.2 Hz, 2H), 7.79 (td, J = 8.0, 1.2 Hz, 2H), 7.56−7.52 (m,
2H). 13C NMR (101 MHz, DMSO-d6): δ 152.0, 151.6, 134.0,
133.4, 129.2, 128.7, 127.8, 124.2. Calcd for C16H8N4O
(272.27): C, 70.58; H, 2.96; N, 20.58. Found: C, 70.46; H,
2.91; N, 20.41.
2-(tert-Butyl)dibenzo[f,h][1,2,5]oxadiazolo[3,4-b]-
quinoxaline (7b). Yield: 157 mg, 96%, red powder. mp 248
°C. 1H NMR (400 MHz, CDCl3): δ 9.15 (s, 1H), 9.07 (d, J =
8.1 Hz, 1H), 8.29 (d, J = 8.1 Hz, 1H), 8.24 (d, J = 8.4 Hz, 1H),
7.86 (dd, J = 8.5, 2.0 Hz, 1H), 7.81−7.76 (m, J = 7.6 Hz, 1H),
7.65−7.59 (m, J = 7.6 Hz, 1H), 1.52 (s, 9H). 13C NMR (101
MHz, CDCl3): δ 152.6, 151.8, 151.7, 151.4, 151.4, 133.8,
133.7, 131.5, 131.2, 128.7, 128.6, 128.6, 128.5, 125.0, 123.3,
123.2, 35.2, 31.2. Calcd for C20H16N4O (328.28): C, 73.15; H,
4.91; N, 17.06. Found: C, 73.18; H, 4.90; N, 17.16.
1,2,3-Trimethoxydibenzo[f,h][1,2,5]oxadiazolo[3,4-b]-
quinoxaline (7c). Yield: 124 mg, 69%, red powder. mp 259 °C.
1H NMR (400 MHz, CDCl3): δ 9.13 (dd, J = 8.1, 1.1 Hz, 1H),
8.23 (d, J = 8.2 Hz, 1H), 7.83−7.77 (m, 1H), 7.68−7.62 (m,
2H), 4.17 (s, 6H), 4.06 (s, 3H). 13C NMR (101 MHz,
CDCl3): δ 157.7, 156.9, 151.5, 151.1, 150.9, 150.1, 145.0,
133.7, 133.4, 131.4, 129.2, 128.73, 128.65, 123.3, 117.5, 102.6,
61.3, 61.1, 56.2. Calcd for C19H14N4O4 (362.35): C, 62.98; H,
3.89; N, 15.46. Found: C, 62.99; H, 4.14; N, 15.44.
4-Fluorodibenzo[f,h][1,2,5]oxadiazolo[3,4-b]quinoxaline
(7d). Yield: 122 mg, 84%, orange powder. mp 252 °C. 1H
NMR (400 MHz, CDCl3): δ 9.25 (d, J = 7.7 Hz, 1H), 9.09 (d,
J = 6.8 Hz, 1H), 8.86 (d, J = 5.0 Hz, 1H), 7.89−7.84 (m, 1H),
7.76−7.70 (m, 1H), 7.69−7.56 (m, 2H). The 13C NMR
spectrum cannot be correctly described in view of the
extremely low solubility of 7d in common organic solvents.19F
NMR (471 MHz, CDCl3): δ 53.53 (dt, J = 13.4, 4.2 Hz).
Calcd for C16H7FN4O (290.26): C, 66.21; H, 2.43; N, 19.30.
Found: C, 66.50; H, 2.34; N, 19.43.
3-Fluorodibenzo[f,h][1,2,5]oxadiazolo[3,4-b]quinoxaline
(7e). Yield: 135 mg, 93%, orange powder. mp 282 °C. 1H
NMR (400 MHz, CDCl3): δ 9.24−9.19 (m, 2H), 8.30 (d, J =
8.2 Hz, 1H), 8.04 (dd, J = 10.2, 2.4 Hz, 1H), 7.91−7.85 (m,
1H), 7.77−7.73 (m, 1H), 7.41 (ddd, J = 9.0, 7.7, 2.5 Hz, 1H).
13C NMR (101 MHz, CDCl3): cannot be correctly described
in view of the extremely low solubility of 7e in common
organic solvents. 19F NMR (376 MHz, CDCl3): δ 58.73 (ddd,
J = 10.3, 7.5, 6.2 Hz). Calcd for C16H7FN4O (290.26): C,
66.21; H, 2.43; N, 19.30. Found: C, 66.23; H, 2.55; N, 19.34.
2-Fluorodibenzo[f,h][1,2,5]oxadiazolo[3,4-b]quinoxaline
(7f). Yield: 114 mg, 78%, orange powder. mp 256 °C. 1H NMR
(500 MHz, CDCl3): δ 9.18 (dd, J = 8.1, 0.8 Hz, 1H), 8.83 (dd,
J = 9.5, 2.8 Hz, 1H), 8.39 (dd, J = 8.9, 5.1 Hz, 1H), 8.32 (d, J =
8.1 Hz, 1H), 7.87−7.83 (m, 1H), 7.72−7.68 (m, 1H), 7.57
(ddd, J = 9.0, 7.5, 2.8 Hz, 1H). 13C NMR (101 MHz, CDCl3):
δ 163.0 (d, 1JC,F = 250.9 Hz), 151.6, 151.5, 151.3, 150.6 (d,
4JC,F = 3.1 Hz), 133.9, 133.1, 131.2 (d,
3JC,F = 8.1 Hz), 130.3
(d, 4JC,F = 3.0 Hz), 129.0, 128.7, 128.6, 125.8 (d,
3JC,F = 8.1
Hz), 123.4, 121.6 (d, 2JC,F = 22.9 Hz), 114.3 (d,
2JC,F = 23.7
Hz). 19F NMR (471 MHz, CDCl3): δ 51.23 (ddd, J = 9.5, 7.5,
5.1 Hz). Calcd for C16H7FN4O (290.26): C, 66.21; H, 2.43; N,
19.30. Found: C, 66.29; H, 2.47; N, 19.24.
2,4-Difluorodibenzo[f,h][1,2,5]oxadiazolo[3,4-b]-
quinoxaline (7g). This substance was not detected in the
reaction mixture by 1H NMR.
1,3-Difluorodibenzo[f,h][1,2,5]oxadiazolo[3,4-b]-
quinoxaline (7h). Yield: 118 mg, 77%, orange powder. mp 269
°C. 1H NMR (400 MHz, CDCl3): δ 9.24 (dd, J = 8.1, 1.2 Hz,
1H), 8.32 (d, J = 8.2 Hz, 1H), 8.01−7.96 (m, 1H), 7.94−7.89
(m, 1H), 7.80 (td, J = 7.7, 1.0 Hz, 1H), 7.23 (ddd, J = 11.5,
8.2, 2.5 Hz, 1H). The 13C NMR spectrum cannot be correctly
described in view of the extremely low solubility in common
organic solvents. 19F NMR (471 MHz, CDCl3): δ 66.81 (dd, J
= 14.9, 11.8 Hz, 1F), 62.03 (ddd, J = 15.7, 9.8, 8.3 Hz, 1F).
Calcd for C16H6F2N2O (308.25): C, 62.34; H, 1.96; N, 18.18.
Found: C, 62.47; H, 1.98; N, 18.16.
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